SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Astute Analytica | PRODUCT CODE: 2172178

Cover Image

PUBLISHER: Astute Analytica | PRODUCT CODE: 2172178

Value-Based Care Enablement Market By Offering, Payment Model, Provider Type, Payer Channel - Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026-2035

PUBLISHED:
PAGES: 280 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF & Excel (Multi User License)
USD 5250
PDF, Excel & PPT (Corporate User License)
USD 6400

Add to Cart

The value-based care enablement market is experiencing substantial growth, driven by the increasing shift from traditional fee-for-service reimbursement models toward healthcare delivery systems that prioritize clinical outcomes, cost efficiency, and quality of care. The market was valued at approximately USD 12 billion in 2025 and is projected to reach USD 55 billion by 2035, expanding at a compound annual growth rate (CAGR) of 16.4% during the forecast period from 2026 to 2035. This significant expansion reflects the growing adoption of technology-enabled solutions that help healthcare providers, insurance companies, and other industry stakeholders implement and manage value-based reimbursement arrangements.

A major factor contributing to market expansion is the increasing adoption of alternative payment models, including shared savings arrangements, bundled payments, accountable care programs, and risk-based capitation. These models encourage healthcare providers to assume greater responsibility for the quality, efficiency, and overall cost of the services they deliver. Consequently, providers are investing in advanced digital infrastructure to coordinate care across hospitals, primary care practices, specialist networks, and other healthcare settings. Population health management platforms are becoming particularly important because they enable organizations to consolidate clinical, claims, and patient utilization data to identify high-risk individuals and support early intervention.

Noteworthy Market Developments

The value-based care enablement market is characterized by the presence of established healthcare technology companies, integrated healthcare service providers, and specialized organizations that help providers and payers transition from traditional fee-for-service reimbursement toward outcome-oriented payment models. The prominent participants in this market are Optum, Aledade, Agilon Health, Privia Health, and Evolent Health, each of which follows a distinct approach to supporting value-based healthcare delivery.

These five companies illustrate the diversity of competitive strategies shaping the value-based care enablement market. Optum emphasizes scale, data analytics, and integrated healthcare services, while Aledade focuses on enabling independent primary care practices to participate in accountable care arrangements. Agilon Health concentrates on long-term physician partnerships and risk-based primary care transformation, whereas Privia Health combines physician network management with centralized technology and operational support. Evolent Health, in contrast, emphasizes specialty care, complex patient populations, and clinical and financial performance improvement.

Their differing approaches reflect the varied needs of healthcare organizations as they transition toward reimbursement models that prioritize quality, efficiency, and measurable outcomes. As adoption of value-based care continues to expand, competition is likely to be shaped by the ability to integrate fragmented healthcare data, demonstrate measurable performance improvements, manage financial risk effectively, and deliver scalable solutions that meet the needs of providers and payers across diverse care settings.

Core Growth Drivers

A major catalyst driving demand for value-based care enablement solutions is the Centers for Medicare & Medicaid Services (CMS) initiative to expand accountable care arrangements across the Traditional Medicare population, with the objective of placing all Traditional Medicare beneficiaries in accountable care relationships by 2030. This ambitious target reflects the broader shift in the United States healthcare system from traditional fee-for-service reimbursement toward payment models that emphasize care quality, patient outcomes, cost efficiency, and provider accountability. The increasing number of Medicare beneficiaries receiving coordinated care through Accountable Care Organizations (ACOs) further illustrates the growing importance of these arrangements within the healthcare delivery landscape. According to the figures cited, more than 14.3 million Medicare beneficiaries are receiving coordinated care through ACOs, representing a 4.4% increase compared with 2025. This expansion highlights the growing role of collaborative care delivery models in improving continuity of care, strengthening preventive health services, and supporting the management of patients with complex or chronic medical conditions.

Emerging Opportunity Trends

The transition from technological novelty toward AI auditability and governed AI execution is emerging as a significant opportunity for growth in the value-based care enablement market. As healthcare providers and payers increasingly integrate artificial intelligence into their operational and clinical workflows, purchasing priorities are shifting from the adoption of innovative AI capabilities toward ensuring transparency, accountability, reliability, and regulatory compliance. Although AI adoption across the healthcare ecosystem has expanded considerably, organizations are becoming more cautious about deploying solutions that cannot adequately explain their recommendations, document their decision-making processes, or demonstrate measurable improvements in clinical and financial performance. The increasing use of third-party AI vendors has further accelerated the need for robust governance frameworks that allow healthcare organizations to evaluate algorithmic performance, manage data privacy risks, and maintain appropriate oversight of automated decisions.

Barriers to Optimization

Data fragmentation and interoperability challenges represent significant barriers to the growth of the value-based care enablement market, as healthcare organizations increasingly depend on the seamless exchange of accurate, comprehensive, and timely patient information to improve clinical outcomes and manage healthcare costs. Healthcare data is often distributed across multiple electronic health record systems, hospital information platforms, insurance claims databases, laboratory systems, pharmacy applications, and other clinical and administrative databases. These systems may operate on different technological architectures, use inconsistent data formats, and follow varying documentation standards, making it difficult to consolidate patient information into a unified and longitudinal health record. The lack of seamless integration can prevent healthcare providers from obtaining a comprehensive understanding of patients' medical histories, treatment patterns, medication use, and existing health conditions. Consequently, fragmented information may lead to duplicated diagnostic tests, delayed clinical decisions, gaps in care coordination, and inefficient utilization of healthcare resources.

Detailed Market Segmentation

By offering, population health platforms are expected to account for the largest share of the value-based care enablement market in 2026, with an estimated market valuation of USD 127 billion. This leading position is primarily driven by the growing need for advanced risk stratification, comprehensive chronic disease management, and coordinated care delivery across increasingly complex healthcare systems. As healthcare providers transition from volume-based reimbursement models toward value-based arrangements, the ability to assess the health status of entire patient populations and identify individuals at elevated risk of developing complications has become increasingly important. Population health platforms address these requirements by combining patient data, clinical insights, and analytical capabilities to help healthcare organizations make informed decisions about care delivery, resource allocation, and preventive interventions.

By payment model, the shared savings model is expected to represent the largest segment of the value-based care enablement market in 2026, generating approximately USD 85 billion in associated market revenue or transactions. This payment framework has gained considerable traction because it provides healthcare organizations with a structured pathway to transition from traditional fee-for-service reimbursement toward more comprehensive value-based care arrangements. Under the shared savings model, participating healthcare providers are encouraged to deliver high-quality, cost-effective care by managing expenditures below an established financial benchmark while meeting predefined quality and performance requirements.

By provider type, health systems are expected to account for the largest revenue share in the value-based care enablement market, generating approximately USD 68 billion in 2026. This leading position is primarily attributable to their extensive operational scale, integrated care delivery networks, substantial financial resources, and ability to manage patients across multiple stages of the healthcare continuum. Health systems typically encompass hospitals, outpatient facilities, specialty care centers, and affiliated physician networks, enabling them to coordinate services across diverse clinical settings. Their broad organizational structures and large patient populations create a strong demand for value-based care enablement solutions that support population health management, care coordination, clinical data integration, financial risk management, and performance measurement.

By payer channel, Medicare Advantage is expected to account for the largest share of the value-based care enablement market in 2026, supported by the growing adoption of capitated payment arrangements and the increasing emphasis on coordinated, outcome-oriented healthcare delivery. Under the Medicare Advantage model, private health insurance plans receive payments from the federal government to provide coverage for eligible beneficiaries, creating incentives to manage healthcare expenditures while maintaining or improving the quality of care. The expansion of these plans has strengthened demand for value-based care enablement solutions that help payers and healthcare providers coordinate services, manage patient populations, monitor clinical performance, and optimize resource utilization.

Segment Breakdown

By Offering

  • Population Health Platforms
  • Risk Adjustment & Coding
  • Care Management & Coordination
  • Quality & Regulatory Reporting
  • Network & Contract Analytics
  • Managed Enablement Services

By Payment Model

  • Shared Savings
  • Bundled Payments
  • Full Capitation
  • Partial Risk

By Provider Type

  • Primary Care Groups
  • Specialty Practices
  • Health Systems
  • Federally Qualified Health Centers

By Payer Channel

  • Medicare Advantage
  • Traditional Medicare (ACO)
  • Medicaid, Commercial

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America
  • Geography Analysis
  • North America is projected to maintain its dominant position in the global market, generating an estimated USD 89 billion in revenue in 2026. This substantial market presence is primarily attributed to the United States, which accounts for approximately 85% of the region's total revenue, reflecting its advanced healthcare infrastructure, extensive adoption of digital health technologies, and strong emphasis on value-based care delivery models. The country's well-established healthcare ecosystem, combined with significant investments in healthcare information technology, data analytics, electronic health records, and integrated care management platforms, continues to accelerate market expansion.
  • A key driver of this growth is the increasing focus of the United States Centers for Medicare & Medicaid Services (CMS) on expanding accountable care arrangements and improving healthcare outcomes while controlling costs. The policy direction toward broader participation in accountable care models, supported by initiatives intended to increase the adoption of value-based payment structures, is encouraging healthcare providers to invest in advanced technological solutions that facilitate care coordination, performance monitoring, patient engagement, and financial risk management.
  • Canada also contributes substantially to North America's market growth through strategic investments in healthcare modernization, digital infrastructure, and the integration of interoperable electronic medical records. Government-led initiatives aimed at strengthening provincial healthcare systems are encouraging the adoption of connected health information platforms that enable the secure exchange of patient data across hospitals, primary care facilities, specialist practices, and other healthcare settings. Investments in digital health infrastructure are expected to improve clinical decision-making, enhance operational efficiency, reduce administrative burdens, and support continuity of care across provincial healthcare networks.

Leading Market Participants

  • Privia Health
  • agilon health
  • Evolent Health
  • Innovaccer
  • Arcadia
  • Health Catalyst
  • Optum
  • Elevance (CarelonRx)
  • Aledade
  • Pearl Health
  • Milliman MedInsight
  • Cotiviti
  • Signify Health (CVS)
  • Clarify Health
  • Lumeris
  • Other Prominent Players
Product Code: AA10262015

Table of Content

Chapter 1. Executive Summary: Global Value-Based Care Enablement Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Value-Based Care Enablement Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Health Data & Interoperability Providers
    • 3.1.2. Population Health & Analytics Platform Developers
    • 3.1.3. Risk Adjustment, Coding & Reporting Solution Providers
    • 3.1.4. Care Management & Enablement Service Providers
    • 3.1.5. Payers & Risk-Bearing Entities
    • 3.1.6. Provider Organisations & Patients (End Users)
  • 3.2. Industry Outlook
    • 3.2.1. Overview of the Global Value-Based Care & Risk-Bearing Enablement Landscape
    • 3.2.2. Shift from Fee-for-Service to Capitation and Shared-Risk Models
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis, By Offering

Chapter 4. Global Value-Based Care Enablement Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Value-Based Care Enablement Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Offering
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Population Health Platforms
        • 5.2.1.1.2. Risk Adjustment & Coding
        • 5.2.1.1.3. Care Management & Coordination
        • 5.2.1.1.4. Quality & Regulatory Reporting
        • 5.2.1.1.5. Network & Contract Analytics
        • 5.2.1.1.6. Managed Enablement Services
    • 5.2.2. By Payment Model
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Shared Savings
        • 5.2.2.1.2. Bundled Payments
        • 5.2.2.1.3. Full Capitation
        • 5.2.2.1.4. Partial Risk
    • 5.2.3. By Provider Type
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Primary Care Groups
        • 5.2.3.1.2. Specialty Practices
        • 5.2.3.1.3. Health Systems
        • 5.2.3.1.4. Federally Qualified Health Centers
    • 5.2.4. By Payer Channel
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Medicare Advantage
        • 5.2.4.1.2. Traditional Medicare (ACO)
        • 5.2.4.1.3. Medicaid
        • 5.2.4.1.4. Commercial
    • 5.2.5. By Region
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. North America
          • 5.2.5.1.1.1. The U.S.
          • 5.2.5.1.1.2. Canada
          • 5.2.5.1.1.3. Mexico
        • 5.2.5.1.2. Europe
          • 5.2.5.1.2.1. Western Europe
            • 5.2.5.1.2.1.1. The UK
            • 5.2.5.1.2.1.2. Germany
            • 5.2.5.1.2.1.3. France
            • 5.2.5.1.2.1.4. Italy
            • 5.2.5.1.2.1.5. Spain
            • 5.2.5.1.2.1.6. Rest of Western Europe
          • 5.2.5.1.2.2. Eastern Europe
            • 5.2.5.1.2.2.1. Poland
            • 5.2.5.1.2.2.2. Russia
            • 5.2.5.1.2.2.3. Rest of Eastern Europe
        • 5.2.5.1.3. Asia Pacific
          • 5.2.5.1.3.1. China
          • 5.2.5.1.3.2. India
          • 5.2.5.1.3.3. Japan
          • 5.2.5.1.3.4. Australia & New Zealand
          • 5.2.5.1.3.5. South Korea
          • 5.2.5.1.3.6. ASEAN
          • 5.2.5.1.3.7. Rest of Asia Pacific
        • 5.2.5.1.4. Middle East & Africa
          • 5.2.5.1.4.1. Saudi Arabia
          • 5.2.5.1.4.2. South Africa
          • 5.2.5.1.4.3. UAE
          • 5.2.5.1.4.4. Rest of MEA
        • 5.2.5.1.5. South America
          • 5.2.5.1.5.1. Argentina
          • 5.2.5.1.5.2. Brazil
          • 5.2.5.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Offering
      • 6.2.1.2. By Payment Model
      • 6.2.1.3. By Provider Type
      • 6.2.1.4. By Payer Channel
      • 6.2.1.5. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Offering
      • 7.2.1.2. By Payment Model
      • 7.2.1.3. By Provider Type
      • 7.2.1.4. By Payer Channel
      • 7.2.1.5. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Offering
      • 8.2.1.2. By Payment Model
      • 8.2.1.3. By Provider Type
      • 8.2.1.4. By Payer Channel
      • 8.2.1.5. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Offering
      • 9.2.1.2. By Payment Model
      • 9.2.1.3. By Provider Type
      • 9.2.1.4. By Payer Channel
      • 9.2.1.5. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Offering
      • 10.2.1.2. By Payment Model
      • 10.2.1.3. By Provider Type
      • 10.2.1.4. By Payer Channel
      • 10.2.1.5. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. Privia Health
  • 11.2. agilon health
  • 11.3. Evolent Health
  • 11.4. Innovaccer
  • 11.5. Arcadia
  • 11.6. Health Catalyst
  • 11.7. Optum
  • 11.8. Elevance (CarelonRx)
  • 11.9. Aledade
  • 11.10. Pearl Health
  • 11.11. Milliman MedInsight
  • 11.12. Cotiviti
  • 11.13. Signify Health (CVS)
  • 11.14. Clarify Health
  • 11.15. Lumeris
  • 11.16. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!